Article
Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2001
Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V M, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A
Abstract excerpt
We examined 483 Finnish breast cancer cases and 482 population controls to determine the potential effect of catechol-O-methyltransferase (COMT) genotype in individual susceptibility to breast cancer. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by unconditional logistic regression after adjustment for known or suspected risk factors for breast cancer. When studied separately by menopausal...
Topics
- Aged
- Aged, 80 and over
- Breast Neoplasms
- Case-Control Studies
- Catechol O-Methyltransferase
- Female
- Genetic Predisposition to Disease
- Genotype
- Humans
- Middle Aged
